First Trust NYSE Arca Biotechnology Index Fund
188 hedge funds and large institutions have $744M invested in First Trust NYSE Arca Biotechnology Index Fund in 2019 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 50 increasing their positions, 83 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
58% less capital invested
Capital invested by funds: $1.77B → $744M (-$1.03B)
63% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 51
67% less funds holding in top 10
Funds holding in top 10: 6 → 2 (-4)
Holders
188
Holding in Top 10
2
Calls
$1.56M
Puts
$687K
Top Buyers
| 1 | +$23M | |
| 2 | +$5.23M | |
| 3 | +$3.03M | |
| 4 |
AIC
Ameritas Investment Company
Lincoln,
Nebraska
|
+$2.65M |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.39M |
Top Sellers
| 1 | -$578M | |
| 2 | -$74.4M | |
| 3 | -$56.6M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$25.9M |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$24.4M |